跳至主要内容
临床试验/EUCTR2015-000578-37-NL
EUCTR2015-000578-37-NL进行中(未招募)1 期

The effect of Nandrolone Decanoate Injection and Leucine Supplementation on Muscle Loss During Immobilisation - Le-Na

Maastricht University Medical Centre+0 个研究点开始时间: 2015年4月13日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Male

入选标准

  • Aged from 18-35 years
  • 18.5 < BMI < 30 kg/m2
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 30
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • (Family) history of thromboembolic events
  • Recent surgery (within 6 months prior to the study)
  • Performing progressive resistance training more than three times per week in the past year
  • Any back/leg/knee/shoulder complaints which may interfere with the use of crutches
  • Current systemic use of corticosteroids, anabolic steroids, growth hormone, testosterone, nandrolone, protein supplements, immunosuppressants or insulin, blood sugar decreasing medication or EPO
  • All co-morbidities interacting with mobility and muscle metabolism of the lower limbs (e.g. arthritis, spasticity/rigidity, all neurological disorders and paralysis)
  • Use of anti-coagulants
  • Pre-existing renal disease or those with a potential risk for renal dysfunction (diabetes, hypertension, reduced glomerular filtration rate)
  • Liver disease
  • Heart failure
  • Allergy to nuts or soy
  • High blood pressure (>140 mmHg systolic and >90 mmHg diastolic)
  • In case of doubt, in- or exclusion of subject will be discussed with responsible physician or principal investigator.

研究者

发起方
Maastricht University Medical Centre+

相似试验